Subjective Cognitive Concerns and Attitudes toward Genetic Testing Are Associated with Depressive Symptoms and Quality of Life after Genetic Testing for the Cerebral Cavernous Malformation Common Hispanic Mutation (CCM1)
- 1 Department of Psychiatry and Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
- 2 Department of Rehabilitation Medicine, Children’s Hospital Colorado and the School of Medicine, University of Colorado Denver, Aurora, CO, USA
- 3 University of New Mexico, Albuquerque, NM, USA
- 4 Department of Neurology and Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
- 5 Department of Radiology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Abstract
Purpose: This study aimed to characterize mood and quality of life and to examine the associations of these areas with subjective cognitive concerns and attitudes toward genetic testing for the Common Hispanic Mutation, a gene that has been associated with increased risk for CCM1. Method: Fifty-four adults with previous genetic testing for the Common Hispanic Mutation completed a mail survey that included assessments of the above identified areas. Results : Self-reported depressive symptoms and quality of life did not differ between those with positive and negative genetic test results. The negative group expressed a more favorable attitude toward genetic testing ( p < 0.001). There was a trend toward more subjective cognitive concerns in the positive group ( p = 0.06). Using generalized linear regression, more subjective cognitive concerns were associated with poorer quality of life and more depressive symptoms ( p < 0.001). Poorer attitude toward genetic testing was also associated with poorer quality of life ( p < 0.05). Conclusions: Subjective cognitive concerns and negative attitudes toward genetic testing may influence emotional well-being after genetic testing for the Common Hispanic Mutation. Additional research is needed that uses objective neuropsychological measures to understand the associations of subjective cognitive concerns, emotional well-being, and cognitive test performance in individuals with CCM1. There is also a need for research that focuses on protective factors and resiliency following genetic testing for CCM1 and the development of mental health interventions to preempt psychosocial difficulties.
- Moriarity, J.L., et al. (1999) The Natural History of Cavernous Malformations: A Prospective Study of 68 Patients. Neurosurgery, 44, 1166-1171. https://doi.org/10.1227/00006123-199906000-00003
- Gunel, et al. (1996) A Founder Mutation as a Cause of Cerebral Cavernous Malformation in Hispanic Americans. New England Journal of Medicine, 334, 946-951. https://doi.org/10.1056/NEJM199604113341503
- Morrison, L. and Akers, A. (2011) Cerebral Cavernous Malformation, Familial. Gene Reviews. http://www.ncbi.nlm.nih.gov/books/NBK1293/#
- Elger, C.E., Helmsteadter, C. and Kurthen, M. (2004) Chronic Epilepsy and Cognition. Neurology, 3, 663-672. https://doi.org/10.1016/S1474-4422(04)00906-8
- Mensah, S.A., Beavis, J.M., Thapar, A.K. and Kerr, M. (2006) The Presence and Clinical Implications of Depression in a Community Sample of Adults with Epilepsy. Epilepsy and Behavior, 8, 213-219. https://doi.org/10.1016/j.yebeh.2005.09.014
- Wiggins, S., et al. (1992) The Psychological Consequences of Predictive Testing for Huntington’s Disease. New England Journal of Medicine, 327, 1401-1405. https://doi.org/10.1056/NEJM199211123272001
- Meiser, B. and Dunn, S. (2000) Psychological Impact of Genetic Testing for Huntington’s Disease: An Update on the Literature. Journal of Neurology, Neurosurgery, and Psychiatry, 69, 574-578. https://doi.org/10.1136/jnnp.69.5.574
- Chao, S., Roberts, S.J., Marteau, T.M., Sillman, R., Cupples, L.A. and Green, R.C. (2008) Health Behavior Changes after Genetic Risk Assessment for Alzheimer’s Disease: The REVEAL Study. Journal of Alzheimer Disease and Associated Disorders, 22, 94-97. https://doi.org/10.1097/WAD.0b013e31815a9dcc
- Roberts, J.S., et al. (2003) Reasons for Seeking Genetic Susceptibility Testing among First-Degree Relatives of People with Alzheimer’s Disease. Journal of Alzheimer Disease Associated Disorders, 17, 86-93. https://doi.org/10.1097/00002093-200304000-00006
- Mendonca, M.D., Alves, L. and Bugalho, P. (2016) From Subjective Cognitive Complaints to Dementia: Who Is at Risk? A Systematic Review. American Journal of Alzheimer’s Disease & Other Dementias, 31, 105-114. https://doi.org/10.1177/1533317515592331
- Heser, K., Tebarth, F., Wiese, B., et al. (2013) Age of Major Depression Onset, Depressive Symptoms, and Risk for Subsequent Dementia: Results of the German Study on Aging, Cognition, and Dementia in Primary Care Patients (AgeCoDe). Psychological Medicine, 43, 1597-1610. https://doi.org/10.1017/S0033291712002449